Literature DB >> 3534091

Synthetic peptides as antigens for the detection of humoral immunity to Plasmodium falciparum sporozoites.

F Zavala, J P Tam, A Masuda.   

Abstract

The presence of antibodies against P. falciparum sporozoites in humans living in malaria-endemic areas was measured using as antigen the synthetic peptide (NANP)3, which represents the immunodominant region of the circumsporozoite (CS) protein. By using a competitive binding assay it was determined that antibodies which recognize (NANP)3 do not react with a 22-Mer synthetic peptide representing a cross-reacting epitope present in an antigen (5.1) from the blood stages of the parasite. Antibodies present in human sera which react with the 5.1 peptide did not react with (NANP)3. This strongly suggests that antibodies to (NANP)3 found in sera of individuals living in endemic areas are a reflection of exposure to P. falciparum sporozoites. These results validate the use of (NANP)3 for epidemiological studies to detect and measure humoral immunity to P. falciparum sporozoites.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3534091     DOI: 10.1016/0022-1759(86)90432-1

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  16 in total

Review 1.  Where are we in the quest for vaccines for malaria?

Authors:  W A Siddiqui
Journal:  Drugs       Date:  1991-01       Impact factor: 9.546

2.  A peptide-based Plasmodium falciparum circumsporozoite assay to test for serum antibody responses to pre-erythrocyte malaria vaccines.

Authors:  Stefan Kostense; Bregje Mommaas; Jenny Hendriks; Mariëlle Verhoeven; Mariska Ter Haak; Felicia Tirion; Edison Wiesken; Maria Grazia Pau; Katarina Radosevic; Jaap Goudsmit
Journal:  Clin Vaccine Immunol       Date:  2011-03-16

3.  ELISA method for detecting Plasmodium falciparum circumsporozoite antibody.

Authors:  R A Wirtz; J F Duncan; E K Njelesani; I Schneider; A E Brown; C N Oster; J B Were; H K Webster
Journal:  Bull World Health Organ       Date:  1989       Impact factor: 9.408

4.  Specific and nonspecific immunodiagnostic properties of recombinant and synthetic Plasmodium falciparum antigens.

Authors:  J Knobloch; M Schreiber; S Grokhovsky; A Scherf
Journal:  Eur J Clin Microbiol       Date:  1987-10       Impact factor: 3.267

Review 5.  Malaria diagnosis: memorandum from a WHO meeting.

Authors: 
Journal:  Bull World Health Organ       Date:  1988       Impact factor: 9.408

Review 6.  Antibody responses to Plasmodium falciparum and P. vivax sporozoites in areas with stable and unstable malaria.

Authors:  G Del Giudice; P H Lambert; K Mendis; A Pessi; M Tanner
Journal:  Bull World Health Organ       Date:  1990       Impact factor: 9.408

7.  Breadth of humoral response and antigenic targets of sporozoite-inhibitory antibodies associated with sterile protection induced by controlled human malaria infection.

Authors:  Kaitian Peng; Yun Shan Goh; Anthony Siau; Jean-François Franetich; Wan Ni Chia; Alice Soh Meoy Ong; Benoit Malleret; Ying Ying Wu; Georges Snounou; Cornelus C Hermsen; John H Adams; Dominique Mazier; Peter R Preiser; Robert W Sauerwein; Anne-Charlotte Grüner; Laurent Rénia
Journal:  Cell Microbiol       Date:  2016-05-27       Impact factor: 3.715

8.  Comparative analysis of ELISAs employing repetitive peptides to detect antibodies to Plasmodium falciparum sporozoites.

Authors:  G Del Giudice; A Douglas; J P Verhave; R A Wirtz; F Zavala
Journal:  Bull World Health Organ       Date:  1989       Impact factor: 9.408

9.  Detection of human antibodies against Plasmodium falciparum sporozoites using synthetic peptides.

Authors:  G Del Giudice; A S Verdini; M Pinori; A Pessi; J P Verhave; C Tougne; B Ivanoff; P H Lambert; H D Engers
Journal:  J Clin Microbiol       Date:  1987-01       Impact factor: 5.948

10.  A role for immune responses against non-CS components in the cross-species protection induced by immunization with irradiated malaria sporozoites.

Authors:  Marjorie Mauduit; Anne Charlotte Grüner; Rita Tewari; Nadya Depinay; Michèle Kayibanda; Jean-Marc Chavatte; Jean-François Franetich; Andrea Crisanti; Dominique Mazier; Georges Snounou; Laurent Rénia
Journal:  PLoS One       Date:  2009-11-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.